rs2710117

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2255+959T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.633 in 152,006 control chromosomes in the GnomAD database, including 30,644 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 30644 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.394

Publications

19 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.644 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.2255+959T>A
intron
N/ANP_054860.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.2255+959T>A
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000455301.2
TSL:3
n.190+959T>A
intron
N/A
CNTNAP2
ENST00000627772.2
TSL:2
n.428+959T>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.633
AC:
96193
AN:
151888
Hom.:
30622
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.620
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.655
Gnomad ASJ
AF:
0.803
Gnomad EAS
AF:
0.626
Gnomad SAS
AF:
0.609
Gnomad FIN
AF:
0.546
Gnomad MID
AF:
0.758
Gnomad NFE
AF:
0.644
Gnomad OTH
AF:
0.676
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.633
AC:
96261
AN:
152006
Hom.:
30644
Cov.:
32
AF XY:
0.629
AC XY:
46692
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.620
AC:
25683
AN:
41434
American (AMR)
AF:
0.654
AC:
10003
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.803
AC:
2784
AN:
3468
East Asian (EAS)
AF:
0.626
AC:
3224
AN:
5154
South Asian (SAS)
AF:
0.609
AC:
2932
AN:
4818
European-Finnish (FIN)
AF:
0.546
AC:
5751
AN:
10542
Middle Eastern (MID)
AF:
0.753
AC:
220
AN:
292
European-Non Finnish (NFE)
AF:
0.644
AC:
43767
AN:
67992
Other (OTH)
AF:
0.678
AC:
1430
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1845
3690
5534
7379
9224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
794
1588
2382
3176
3970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.631
Hom.:
3793
Bravo
AF:
0.642
Asia WGS
AF:
0.628
AC:
2185
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.89
DANN
Benign
0.52
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2710117; hg19: chr7-147601772; API